Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 6.54M | $ 25.67M | $ 30.33M | $ 11.82M | $ 8.60M |
Total Assets | $ 129.52M | $ 133.76M | $ 130.99M | $ 119.88M | $ 129.08M |
Total Debt | $ 72.83M | $ 68.65M | $ 77.52M | $ 78.93M | $ 93.17M |
Net Debt | $ 66.29M | $ 42.98M | $ 47.20M | $ 67.11M | $ 84.58M |
Total Liabilities | $ 95.79M | $ 96.01M | $ 105.28M | $ 101.18M | $ 116.91M |
Stockholders Equity | $ 39.93M | $ 42.21M | $ 29.57M | $ 22.27M | $ 16.09M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |